BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6347668)

  • 1. Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro.
    Boquist L; Nelson L; Lorentzon R
    Endocrinology; 1983 Sep; 113(3):943-8. PubMed ID: 6347668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of isolated mitochondria incubated with labelled and non-labelled alloxan, with regard to intramitochondrial concentrations of reduced glutathione and inorganic phosphate.
    Boquist L; Ponten E; Sandström E
    Diabete Metab; 1983; 9(2):106-11. PubMed ID: 6617930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
    Boquist L
    Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic uptake of [2-(14)C]alloxan.
    Malaisse WJ; Doherty M; Ladrière L; Malaisse-Lagae F
    Int J Mol Med; 2001 Mar; 7(3):311-5. PubMed ID: 11179513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloxan uptake by isolated rat islets of Langerhans.
    Weaver DC; McDaniel ML; Lacy PE
    Endocrinology; 1978 Jun; 102(6):1847-55. PubMed ID: 369835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic fate of 14C-labelled hexoses.
    Malaisse WJ; Ladriere L; Kadiata MM; Malaisse-Lagae F
    Cell Biochem Funct; 2000 Dec; 18(4):281-91. PubMed ID: 11180291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses.
    Boquist L
    Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):219-29. PubMed ID: 322443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of Langerhans.
    Blomqvist M; Osterbye T; Månsson JE; Buschard K; Fredman P
    Lipids Health Dis; 2006 Oct; 5():26. PubMed ID: 17044925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein does not protect mouse endocrine cells from damage induced by alloxan injection.
    Minami T; Shimizu M; Tanaka H; Okazaki Y; Cherian MG
    Toxicology; 1999 Jan; 132(1):33-41. PubMed ID: 10199579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse.
    Dunning BE; Ahrén B
    Acta Physiol Scand; 1993 Oct; 149(2):215-9. PubMed ID: 7505518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the beta-cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances.
    Boquist L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):556-61. PubMed ID: 354301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloxan effects on mitochondria in vitro, studied with regard to inhibition of mitochondrial aconitase.
    Boquist L; Boström T
    Diabete Metab; 1985 Aug; 11(4):232-7. PubMed ID: 4043490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anomers of D-glucose on alloxan inhibition of insulin release in isolated perifused pancreatic islets.
    McDaniel ML; Roth CE; Fink CJ; Lacy PE
    Endocrinology; 1976 Aug; 99(2):535-40. PubMed ID: 782855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of tritiated glibenclamide by endocrine and exocrine pancreas.
    Ladrière L; Malaisse-Lagae F; Malaisse WJ
    Endocrine; 2000 Aug; 13(1):133-6. PubMed ID: 11051057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alloxan on the islets of Langerhans: stimulation and inhibition of cyclic AMP production.
    Borg LA; Bone AJ
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):361-9. PubMed ID: 2993386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation.
    Park BH; Park JW
    Exp Mol Med; 2001 Jun; 33(2):64-8. PubMed ID: 11460883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrastructural analysis of the effect of alloxan on the cellular elements of the pancreas in reptiles].
    Iaglov VV
    Biull Eksp Biol Med; 1977 Aug; 84(8):245-7. PubMed ID: 332252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.